Abstract
Parkinsonism is seen in patients with disease of the extrapyramidal system. The key components of parkinsonism are rigidity and bradykinesia. The presence of tremor, asymmetry, cognitive decline, cerebellar abnormalities, and autonomic dysfunction helps to define the cause. Parkinson disease (PD) is the most common of the parkinsonian syndrome, and is defined by asymmetric resting tremor, bradykinesia, and rigidity. Patients with PD respond to levodopa in the early stages of the disease, but become less responsive and develop more drug-related side effects and disability as the disease progresses. Progressive supranuclear palsy usually presents with gait difficulty, and the key diagnostic clue is difficulty with downward saccadic eye movements. Multiple system atrophy may include cerebellar and autonomic features that overshadow the extrapyramidal ones. Corticobasal degeneration is an extrapyramidal disorder with cognitive and behavioral abnormalities including prominent limb apraxia. Parkinsonism may be related to drugs (particularly neuroleptic agents) or cerebrovascular disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson’s disease. Mov Disord. 2006;20:1255–63.
Ahlskog JE, Uitti RJ. Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction? Neurology. 2010;74:1143–8.
de la Fuente-Fernandez R. Role of DaTSCAN and clinical diagnosis in Parkinson disease. Neurology. 2012;78:696–701.
Faber R, Trimble MR. Electroconvulsive therapy in Parkinson’s disease and other movement disorders. Mov Disord. 1991;6:293–303.
Ghika J, Bogousslavsky J. Abnormal movements. In: Bogousslavsky J, Caplan L, editors. Stroke syndromes. Cambridge: Cambridge University Press; 2001. p. 162–81.
Hardie RJ, Lees AJ. Neuroleptic-induced Parkinson’s syndrome: clinical features and results of treatment with levodopa. J Neurol Neurosurg Psychiatry. 1988;51:850–4.
Hardy J, Cai H, Cookson MR, Gwinn-Hardy K, Singleton A. Genetics of Parkinson’s disease and parkinsonism. Ann Neurol. 2006;60:389–98.
Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology. 1992;42:1142–6.
Jankovic J, Schwartz J, Vander Linden C. Comparison of sinemet CR4 and standard sinemet: double blind and long-term open trial in parkinsonian patients with motor fluctuations. Mov Disord. 1989;4:303–9.
Kato N, Arai K, Hattori T. Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci. 2003;15:57–60.
Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord. 2006;21:S290–304.
Mayeux R, Stern Y, Rosen J, Leventhal J. Depression, intellectual impairment, and Parkinson disease. Neurology. 1981;31:645–50.
Miyasaki JM, Shannon K, Voon V, et al. Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review). Neurology. 2006;66:996–1002.
Nath U, Ben-Shlomo Y, Thomson RG, Lees AJ, Burn DJ. Clinical features and natural history of progressive supranuclear palsy. A clinical cohort study. Neurology. 2003;60:910–6.
Pinto S, Ozsancak C, Tripoliti E, et al. Treatments for dysarthria in Parkinson’s disease. Lancet Neurol. 2004;3:547–56.
Pondal M, Marras C, Miyasaki J, et al. Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic. J Neurol Neurosurg Psychiatry. 2013;84:130–5.
Schrag A, Ben-Shlomo Y, Brown R, Marsden CD, Quinn N. Young-onset Parkinson’s disease revisited—clinical features, natural history, and mortality. Mov Disord. 1998;13:885–94.
Wenning GK, Litvan I, Jankovic J, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry. 1998;64:184–9.
Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol. 2004;3:93–103.
Winge K, Rasmussen D, Werdelin LM. Constipation in neurological diseases. J Neurol Neurosurg Psychiatry. 2003;74:13–9.
Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol. 1999;56:98–102.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Tarulli, A. (2016). Parkinsonism. In: Neurology. Springer, Cham. https://doi.org/10.1007/978-3-319-29632-6_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-29632-6_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-29630-2
Online ISBN: 978-3-319-29632-6
eBook Packages: MedicineMedicine (R0)